NewsBenzingaOculis obtient l’autorisation de la FDA pour l’IND de Privosegtor dans les poussées aiguës de SEP, y compris la névrite optique et les poussées ambulatoires, avec un critère d’évaluation principal dès trois mois Oculis obtient l’autorisation de la FDA pour l’IND de Privosegtor dans les poussées aiguës de SEP, y compris la névrite optique et les poussées ambulatoires, avec un critère d’évaluation principal dès trois mois Benzinga 2026.11.16 07:07 (GMT+0) Open on Benzinga Other news Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It Taiwan Semiconductor (TSM) Stock Trending After Nvidia Posts Strong Q3 Results: What You Should Know Binance Spot and Convert Add 7 bStocks Trading Pairs ‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions Verisk Analytics, Inc. (VRSK) Presents at J.P. Morgan Ultimate Services Investor Conference 2026 Transcript
Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It
‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work
Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions
Verisk Analytics, Inc. (VRSK) Presents at J.P. Morgan Ultimate Services Investor Conference 2026 Transcript